| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.037 | 0.5 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |